Northwest Financial Statements From 2010 to 2024
| NWBO Stock | USD 0.27 0.01 3.85% |
Check Northwest Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Northwest Biotherapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Northwest financial statements analysis is a perfect complement when working with Northwest Biotherapeutics Valuation or Volatility modules.
Northwest |
Northwest Biotherapeutics OTC Stock Return On Asset Analysis
Northwest Biotherapeutics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Northwest Biotherapeutics Return On Asset | -1.26 |
Most of Northwest Biotherapeutics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Northwest Biotherapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Northwest Biotherapeutics has a Return On Asset of -1.2576. This is 85.63% lower than that of the Biotechnology sector and 94.67% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Northwest Biotherapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Northwest Biotherapeutics's current stock value. Our valuation model uses many indicators to compare Northwest Biotherapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Northwest Biotherapeutics competition to find correlations between indicators driving Northwest Biotherapeutics's intrinsic value. More Info.Northwest Biotherapeutics is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Northwest Biotherapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Northwest Biotherapeutics' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Northwest Biotherapeutics Financial Statements
Northwest Biotherapeutics investors utilize fundamental indicators, such as revenue or net income, to predict how Northwest OTC Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company was founded in 1996 and is headquartered in Bethesda, Maryland. Northwest Bioth operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 19 people.
Pair Trading with Northwest Biotherapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Northwest Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Northwest Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Northwest OTC Stock
| 0.48 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
| 0.36 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.36 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
| 0.34 | FBIOP | Fortress Biotech Pref | PairCorr |
| 0.31 | EVLO | Evelo Biosciences | PairCorr |
The ability to find closely correlated positions to Northwest Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Northwest Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Northwest Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Northwest Biotherapeutics to buy it.
The correlation of Northwest Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Northwest Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Northwest Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Northwest Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Northwest OTC Stock
Northwest Biotherapeutics financial ratios help investors to determine whether Northwest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Northwest with respect to the benefits of owning Northwest Biotherapeutics security.